Investing in HealthTronics
Home :
Investing in HealthTronics
HealthTronics (NASDAQ: HTRN) is a urological products and services company that offers a comprehensive range of diagnostic and therapeutic solutions to physicians, hospitals, surgery centers and clinics. The company is both a manufacturer and a provider of surgical services to the urology community.
Our product portfolio includes a full line of urology equipment and products including lithotripters, surgical lasers for treatment of BPH, and anatomical pathology services.
As a service provider, HealthTronics offers the latest technology in lithotripsy services and prostate therapy services including BPH treatments and prostate cancer treatments.
As a shareholder or potential investor, you can find everything you need to know about investing in HealthTronics right here. Please use the menu to the left.
Security analysts, portfolio managers and representatives of financial institutions seeking information about HealthTronics should contact:
Investor Relations Inquiries
Becky Hobgood, Special Projects Accountant
Investor Relations e-mail: info@healthtronics.com
Investor Relations telephone: (888) 948-1970
Investor Relations fax: (512) 314-4305
HealthTronics
9825 Spectrum Dr., Building 3
Attn: Investor Relations
Austin, Texas 78717
Media Inquiries
Lisa Carrell, Marketing Communication Specialist
(888) 252-6575
Transfer Agent and Registrar
American Stock Transfer & Trust Company
New York, NY
Shareholder Services:
(800) 937-5449
(212) 936-5100
Recent Presentations
Statements in this website that are not strictly historical, including statements regarding plans, objective and future financial performance, are “forward-looking” statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although HealthTronics believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that the expectations will prove to be correct. Factors that could cause actual results to differ materially from HealthTronic’s expectations include, among others, the existence of demand for and acceptance of HealthTronic’s services, the availability of appropriate candidates for acquisition by HealthTronics, regulatory approvals, economic conditions, the impact of competition and pricing, financing efforts and other factors described from time to time in HealthTronic’s periodic filings with the Securities and Exchange Commission.
|
